NCT04771923View on ClinicalTrials.gov

Tranexamic Acid Versus Adrenaline for Controlling Iatrogenic Endobronchial Bleeding

NACompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

February 22, 2021

Primary Completion Date

February 4, 2022

Study Completion Date

February 4, 2022

Conditions
BleedingHemoptysis
Interventions
DRUG

Tranexamic acid

Topical instillation of tranexamic acid up to 3x. If bleeding is not controlled patients crossover to adrenaline.

DRUG

Adrenaline

Topical instillation of adrenaline up to 3x. If bleeding is not controlled patients crossover to tranexamic acid.

Trial Locations (1)

10000

Clinical Hospital Centre Zagreb, Zagreb

All Listed Sponsors
lead

Clinical Hospital Centre Zagreb

OTHER

NCT04771923 - Tranexamic Acid Versus Adrenaline for Controlling Iatrogenic Endobronchial Bleeding | Biotech Hunter | Biotech Hunter